NL264270A - - Google Patents
Info
- Publication number
- NL264270A NL264270A NL264270DA NL264270A NL 264270 A NL264270 A NL 264270A NL 264270D A NL264270D A NL 264270DA NL 264270 A NL264270 A NL 264270A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/06—Aluminium compounds
- C07F5/069—Aluminium compounds without C-aluminium linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
NL264270A true NL264270A (en) |
Family
ID=1864713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL264270D NL264270A (en) |
Country Status (1)
Country | Link |
---|---|
NL (1) | NL264270A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2451713A (en) * | 2007-02-06 | 2009-02-11 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
-
0
- NL NL264270D patent/NL264270A/xx unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2451713A (en) * | 2007-02-06 | 2009-02-11 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
GB2451713B (en) * | 2007-02-06 | 2009-12-16 | Medical Res Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
US8058462B2 (en) | 2007-02-06 | 2011-11-15 | Medical Research Council | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8058462B2 (en) | Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation | |
AU2001295589B2 (en) | Regioselective liquid phase pegylation | |
AU1676992A (en) | Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers | |
AU2004305291A1 (en) | Branched polyethylene glycol for linking polymer residues to antibodies | |
ATE200030T1 (en) | PEGYLATION PROCEDURE | |
ATE410432T1 (en) | DIARYLPHENOXY ALUMINUM COMPOUNDS | |
AU2003251002B2 (en) | Bisacyloxypropylcysteine conjugates and the use thereof | |
JP2010520856A5 (en) | ||
ATE118686T1 (en) | BIOLOGICALLY EFFECTIVE POLYMERIC DRUG DERIVATIVES. | |
AU2003263890A8 (en) | Lewis acid ionic liquids | |
ATE533772T1 (en) | SYNTHESIS OF BIGUANIDES AND TRIAZINES AND BIGUANINE-ALUMINUM COMPLEXES AS INTERMEDIATE PRODUCTS | |
ATE172216T1 (en) | CONJUGATES OF CALCITONIN AND POLYETHYLENE GLYCOL | |
AT244989B (en) | Process for the production of aluminum isopropoxide | |
AR207022A1 (en) | PROCEDURE FOR THE PREPARATION OF POLY-N-DIMETHYLIMINOALANE | |
AU2002363791A1 (en) | Protease enzyme inhibitors | |
ATE120373T1 (en) | NON-SPECIFIC IMMUNOMODULATOR AGENT AND METHOD FOR THE PRODUCTION THEREOF. | |
AU1270101A (en) | Interferon gamma conjugates | |
NL264270A (en) |